ArticlePloS one2025
Diet-induced steatohepatitis does not cause heart failure with preserved ejection fraction in male middle-aged C57BL/6N mice.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Metabolic dysfunction-associated steatohepatitis (MASH) is a condition characterized by inflammation and liver fibrosis. MASH patients are at a high risk of developing heart failure with preserved ejection fraction (HFpEF), thus raising the question of whether liver dysfunction directly or indirectly leads to HFpEF. Diet-induced murine liver disease models are well established; however, it is not clear whether these mice develop HFpEF. In this work, we studied the metabolic pathophysiological effects of two formulated diets, including a high fat (HF) diet, and a high fat, high fructose, high cholesterol diet (HFFC). Both the HF and the HFFC diets induced obesity and liver steatosis, with the HF diet being more potent in increasing adipose tissue volume and the HFFC diet being more potent in increasing hepatocyte lipid storage. Additionally, the HFFC diet, not the HF diet, caused liver inflammation and fibrosis. Although the HFFC diet induced steatohepatitis in treated mice, these mice had normal cardiac function and histology. In conclusion, our data demonstrate that HFFC diet-stress induces MASH without harming the heart and suggest that liver dysfunction is not sufficient to cause HFpEF in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.